Skip to main content

NYVEPRIA

NDC 0069-0324 · Pfizer Laboratories Div Pfizer Inc

Generic namepegfilgrastim-apgf
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)PEGFILGRASTIM
Strength6 mg/.6mL
Pharmacologic classGranulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
Marketing categoryBLA

Packages

0069-0324-01 — 1 CARTON in 1 CARTON (0069-0324-01) / 1 SYRINGE in 1 CARTON / .6 mL in 1 SYRINGE

Billed under HCPCS

Q5122 — Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg Medicare Part B payment limit (ASP + 6%): $136.91

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55513-099 — pegfilgrastim, 55513-190 — pegfilgrastim, 61314-866 — pegfilgrastim-bmez, 65219-371 — pegflilgrastim-fpgk, 69448-025 — pegfilgrastim-cbqv, 69448-026 — pegfilgrastim-cbqv, 69448-027 — pegfilgrastim-cbqv, 70114-101 — pegfilgrastim-cbqv, 70114-120 — pegfilgrastim-cbqv, 70114-130 — pegfilgrastim-cbqv, 70121-1627 — pegfilgrastim, 70748-273 — pegfilgrastim-unne, 72603-402 — pegflilgrastim-fpgk, 83257-005 — pegfilgrastim-jmdb

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.